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Abstract 
The aim of this study was to investigate the mechanism underlying autophagy deficiency 
during hepatic carcinogenesis. For this purpose, we used choline-deficient, amino 
acid-defined (CDAA) hepatocarcinogenesis model in mice. miRNA microarrays 
combined with computational target predictions and GO analysis were used to identify 
molecular processes involved in carcinogenesis. PCR profiler array was employed to 
detect the dysregulated autophagy-related genes during carcinogenesis. We observed 
induction of hepatic tumours with increased inflammation, DNA damage, and cell death. 
These cellular processes were particularly detected upon oncogenic transformation of 
hepatocytes in which ER stress was excessively induced. Microarray combined with GO 
analysis showed that transformation of hepatocytes resulted in dysregulated events 
associated with cytoplasmic vesicle formation, which, in turn, was related to ER 
stress-induced autophagy. Defects of autophagy were observed in livers harbouring 
tumours and suffered a loss of expression of autophagy-related protein 9b (Atg9b). 
Hepatocytes lacking Atg9b were vulnerable to cell death induced by ER stress stimulus 
mainly caused by accumulation of ubiquitinated proteins. Loss of Atg9b also blocked 
recruitment of p62-associated ubiquitinated protein for autophagosome-lysosome 
degradation as Atg9b-driven phagophores may facilitate docking of both LC3 and p62 to 
initiate autophagy-associated degradation. miR-3091-3p from tumour-derived exosomes, 
which were internalised by hepatocytes, could suppress Atg9b expression. Observations 
from this study advance our knowledge about the regulation of autophagy during 
hepatocarcinogenesis. 
Key words: Hepatic carcinogenesis; Autophagy; Atg9b; ER stress; Tumour-derived exosome; microRNA. 
Introduction 
Several lines of evidence have suggested the 
protective role of autophagy during carcinogenesis of 
the liver. Autophagy may prevent inflammation, 
fibrosis, and carcinogenesis in the liver of alpha-1- 
antitrypsin (AT)-deficient rodents by mediating the 
degradation of this mutant protein [1, 2]. Using 
autophagy-enhancing chemical successfully 
decreased the hepatic load of protein aggregates and 
prevented liver from injury and fibrogenesis [2]. The 
essential role of autophagy was further proven by the 
observation that lysosome inhibitors may accelerate 
hepatocarcinogenesis in genotoxin-treated rodents 
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[3]. Blocking initiation of autophagy by chronic 
activation of mTOR signalling, an upstream negative 
regulator of autophagy, is able to initialise 
endoplasmic reticulum (ER) stress in hepatocytes, 
which contributes to hepatic damage and 
inflammation-associated carcinogenesis [4]. 
Liver-specific knockout of autophagy-associated gene 
5 (Atg5), which impairs autophagy in the liver, 
acquires hepatocarcinogenesis in mice at 10-months of 
age [5]. Defects of autophagy render hepatocytes 
vulnerable to a variety of metabolic stresses resulting 
in cell death and hepatic inflammation [6] while 
inducing hepatic autophagy in mice under carcinogen 
treatment can suppress oxidative stress and genome 
instability [7]. Although these observations provide 
evidence that autophagy is a promising target for 
cancer prevention, how autophagy is regulated 
during hepatocarcinogenesis remains unclear. 
Autophagy is a highly conserved biological 
process that maintains intracellular homeostasis by 
recycling damaged cell components and scavenging 
harmful substrates such as damaged organelles and 
protein aggregates [8]. Initiation and regulation of 
cellular autophagy are under strict control and 
involve regulation of a series of autophagy-associated 
proteins [9]. Ablation or mutation of these genes, 
which commonly occurs in cancer patients, abrogates 
autophagy initiation and may be of pathological and 
prognostic significance. Autophagy was found 
down-regulated in hepatocellular carcinoma (HCC) 
specimens collected from patients with or without 
detectable hepatitis viruses and low expression of 
Atg5 was found correlated with increased virus 
burden [10]. Interestingly, p62 accumulation caused 
by autophagy deficiency could be observed in HCC 
specimens regardless of the virus status [10, 11]. 
Down-regulation of autophagy-related genes has 
been shown to be correlated with poor prognosis in 
HCC patients [12]. Similarly, a significant decrease in 
expression of Beclin-1 was found in HCC tissues, 
which was correlated with diseases-free survival and 
overall survival in patients with Bcl-xL expression 
[13]. Beclin-1 expression in HCC patients was 
reported to have a negative correlation with cirrhosis 
as well as vascular invasion [14]. These observations 
point to the clinical importance of the expression of 
autophagy-related genes for HCC prognosis. 
In this report, we used choline deficient, amino 
acid-defined (CDAA) hepatocarcinogenesis model in 
mice to study the expression of autophagy-associated 
genes during early hepatocarcinogenesis. Feeding 
mice with CDAA diet leads to the development of 
non-alcoholic steatohepatitis/non-alcoholic fatty liver 
disease (NASH/NAFLD) and subsequent 
hepatocellular adenomas and carcinoma, which 
imitate hepatocarcinogenesis in humans [15]. We 
hypothesized that the link between autophagy 
deficiency and hepatocarcinogenesis can be 
elaborated with profiling of microRNAs (miRNAs) in 
combination with computational analysis. With PCR 
profiler array of autophagy-related genes, we 
identified the role of autophagy-related protein 9b 
(Atg9b), the deletion of which causes early embryonic 
lethality [16], in mediating autophagy deficiency 
during hepatocarcinogenesis. Furthermore, we 
elucidated the detailed mechanism underlying the 
role of Atg9b in initiating autophagy in response to 
ER stress. 
Results 
NAFLD mice accelerate hepatic inflammation 
and hepatocyte death during 
hepatocarcinogenesis 
HCC commonly arises in patients with chronic 
liver diseases, especially NAFLD and is therefore 
considered a typical inflammation-related cancer. The 
cellular and molecular process of cancerous switch of 
NAFLD has just begun to be understood. To observe 
the pathological changes during 
hepatocarcinogenesis, we collected specimens of 
CDAA diet-fed mice at week 32, 56 and 72. While 
there was no hepatic tumour in mice after 32weeks, 
carcinogenesis in the liver was evident after 56 weeks 
(Fig.1a). Five out of ten mice presented hepatic 
tumours after 56-week treatment and all CDAA 
diet-fed mice had liver tumors after 72 weeks. No 
hepatic tumour was observed in mice fed with CSAA 
diet of standard chow. Descriptive analysis on the 
specimen is shown in Supplemental Table 1. 
Biochemical analysis showed significantly elevated 
activity of the serum ALT in CDAA diet-fed mice 
compared with the standard chow-fed group 
(Supplemental Figure 1). CDAA diet-fed mice 
presented serious NASH accompanied with 
significant accumulation of lipid droplets in the liver 
(Supplemental Figure 2). Histological analysis of liver 
tumours in mice with CDAA feeding exhibited 
various patterns predominantly with fatty changes 
and solid growth. Some cases developed cytoplasmic 
inclusions and trabecular growth (Fig.1b and 
Supplemental Figure 3). The microscopic analysis of 
the liver from individual CDAA diet-fed mice is 
shown in Fig.1c. Mice fed with CDAA diet showed 
increased infiltration of macrophages into the liver 
(Fig.1d). Specifically, CDAA diet-fed mice with 
hepatic tumours (T) exhibited a significantly higher 
level of liver inflammation (Fig.1e) as well as 
inflammatory monocytes in the peripheral blood 
(Supplemental Figure 4) than those without tumour 
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(NT). This observation indicated that 
hepatocarcinogenesis may be accompanied by 
increased chronic inflammation that facilitates 
progression of liver tumour. This was further 
supported by the evidence that expression of 
inflammation markers IL6, IL1β and TNFα were 
increased particularly in the livers of CDAA diet-fed 
mice with hepatic tumours (Supplemental Figure 5). 
Increased apoptosis of hepatocytes in the livers of 
mice with hepatic tumours was observed (Fig.1f), 
while mice without tumours showed decreased cell 
death in hepatocytes (Fig.1g)  
 
 
 
Figure 1. Hepatocarcinogenesis is accompanied by excessive inflammation and cell death of hepatocytes in CDAA diet-fed mice a) 
macromorphology of livers. Tumours could be observed after mice received CDAA diet for 56 and 72 weeks; tumor size increased with feeding time. 
CSAA diet did not cause formation of visible liver tumors in mice; b) histological analysis of livers. Mice developed liver tumors with various growth 
patterns. c) growth patterns in CDAA diet-fed mice. Columns depict individual mice; d) representative pictures of macrophage infiltration in the livers 
from CSAA diet-fed mice (CSAA), CDAA diet-fed mice with tumor (T) or without hepatic tumor (NT) after 56 weeks. E) analysis of grade of hepatic 
inflammation as represented by macrophage infiltration. Each dot depicts one individual mouse; f) increase in cell death of hepatocytes in CDAA diet-fed 
mice at 56 weeks; g) analysis of grade of cell death. Each dot depicts one individual mouse. 
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Peritumor hepatocytes present increased ER 
stress during hepatocarcinogenesis 
Progressive ER stress was previously implicated 
in hepatocyte apoptosis in Acyl-Coenzye A oxidase 
1-deficient mice during hepatocarcinogenesis [17]. 
CDAA diet progressively increased ER stress in the 
liver of mice compared with CSAA diet (CS). 
However, there was a remarkable increase in ER 
stress in mice with tumors (T) when compared with 
those without tumors (NT) (Fig. 2a). Analysis of 
expression of related genes revealed that livers with 
tumors possessed accelerated ER stress (Fig.2b), 
though non-tumor livers from CDAA diet-fed mice 
also had a moderate level of ER stress. In particular, 
when we isolated hepatocytes from livers with or 
without tumors, hepatocytes from livers with tumors 
had a significantly higher level of ER stress and 
apoptosis than those from non-tumor livers (Fig. 2c & 
d). These observations suggested that there were 
some molecular changes during the cancerous 
transformation of hepatocytes in CDAA diet-induced 
NAFLD mice. To identify the molecular events during 
hepatocarcinogenesis, microarray study was 
conducted to analyse the differential expression of 
hepatic murine microRNAs (miRNAs) that may 
regulate broad biological processes in hepatocytes. 
Differential expression profiles of miRNAs in 
hepatocytes from non-tumour or tumoral livers of 
CDAA diet-fed mice were collected (Fig. 2e). Subsets 
of miRNAs that were up-regulated or down-regulated 
in non-tumour livers compared with miRNAs 
expressed in livers with tumour were identified 
(Supplemental Table 2). 8 miRNAs exhibited a 
significant up-regulation in liver with tumours 
compared with non-tumour liver while 16 were 
significantly down-regulated (Fig. 2e). To understand 
the possible biological process involved, we 
computationally predicted potential targets of 
miRNAs with a significant difference between groups 
by target mining at miRDB 
(http://mirdb.org/miRDB/). The predicted genes 
with most abundance equivalence were then followed 
with GO analysis on DAVID 
(https://david.ncifcrf.gov/). The possible cellular 
components regulated by genes with potential change 
in expression were annotated with count threshold of 
three genes. The analysis revealed that both up- and 
down-regulated genes were mainly involved in the 
cellular processes associated with cytoplasmic 
vesicles and membrane delivery (Fig. 2f).  
Autophagy is defective in hepatocytes during 
hepatic carcinogenesis 
It has previously been shown that during ER 
stress, an important cellular process associated with 
cytoplasmic vesicles is the autophagy [18]. ER stress 
can trigger autophagy as a critical step in relieving 
cellular stress and prevent cell death and genomic 
instability [19]. Activation of unfolded protein 
response (UPR) could initiate autophagy to deposit 
misfolded proteins, an adaptive mechanism to 
prevent cell death in response to excessive 
intracellular ER stress [20]. We therefore assessed if 
autophagy was induced upon UPR in the liver of 
CDAA diet-fed mice. Intensive autophagy was 
observed in the liver of mice without hepatic tumor, 
however, autophagic punctuation was surprisingly 
blocked in those with tumor (Fig. 3a). 
Immunoblotting showed that hepatocytes from mice 
with tumors had defective autophagy, as evidenced 
by defective LC3 conversion as well as accumulation 
of p62 adaptor protein (Fig. 3b). This collectively 
showed that in hepatocytes from livers with tumors, 
the level of autophagy was comparatively lower than 
that in hepatocytes from livers without tumors, 
suggesting that carcinogenic process was 
accompanied with deficient autophagy. To further 
clarify the issue, we also checked the mRNA 
expression of LC3B in human samples and murine 
tissues. By analysing data from the Oncomine 
database, we found that expression of LC3B was not 
significantly changed in HCC tissues compared with 
adjacent non-tumor hepatic tissues (Supplemental 
Figure 6). Using quantitative real-time PCR 
(qRT-PCR), we confirmed that mRNA expression of 
LC3B was not significantly suppressed in hepatocytes 
from livers with tumors (Supplemental Figure 6). 
Previous study has shown that although transcription 
of LC3B may be induced to replenish the cytoplasmic 
level of LC3B protein that was turned over during 
excessive autophagy, transcription initiation of LC3B 
is not required for autophagy induction [21]. p62 is an 
adaptive protein involved in the autophagic 
deposition of misfolded proteins during ER stress 
[22]. Accumlation of p62, a gene that positively 
regulates the autophagy process, has been observed 
during diethylnitrosamine (DEN)-induced 
hepatocarcinogenesis in MAP1S-deficient mice [7]. 
Co-localization of p62 with ubiquitinated proteins 
facilitates autophagic degradation of these protein 
aggregates. We detected a high concentration of 
co-localized p62 and ubiquitin-tagged proteins in the 
hepatocytes from livers that harboured tumors (Fig. 
3c). Interestingly, deposition of p62-ubuiqinated 
protein complex was specifically observed in the 
peritumor hepatocytes indicating its potential role in 
the cancerous transformation of the cells. Activation 
of autophagy was observed in the liver of CSAA 
diet-fed mice compared with mice fed with standard 
chow, possibly due to the moderate ER stress. 
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Surprisingly, induction of autophagy was less 
observed in the hepatocytes of livers with tumors in 
CDAA diet-fed mice.  
 
 
Figure 2. Hepatocarcinogenesis accelerates ER stress in the livers of mice a) mice with hepatic tumors exhibit increased expression of the ER stress 
markers GRP78 and CHOP at 56 weeks; b) expression of ER stress-related genes in hepatocytes from CSAA diet-fed mice (CSAA), CDAA diet-fed mice with tumors 
(T) or without hepatic tumors (NT) at 56 weeks; c) quantification of ER stress-related proteins in CDAA diet-fed mice with tumors (T) or without hepatic tumors 
(NT); d) quantification of DNA damage markers in CDAA diet-fed mice with (T) or without hepatic tumour (NT); e) miRNAs with significant differences in 
expression across different samples; f) functional annotation of predicted target genes of miRNAs by GO analysis. Target prediction was conducted by miRDB and 
functional annotation for cellular component of predicted genes was performed with GO analysis. 
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Figure 3. Autophagy was inhibited in hepatocytes during carcinogenesis a) reduced LC3 punctuation in the tumour-bearing livers of CDAA diet-fed mice 
at 56-weeks; b) defective activation of LC3 in CDAA diet-fed mice with liver tumors at 56-weeks leading to accumulation of p62; c)p62 was specifically accumulated 
in the peritumor areas and co-localized with ubiquitin-tagged proteins in CDAA diet-fed mice with hepatic tumors (T) compared with those without tumour (NT); 
d) scatter plots of expression of autophagy-related genes between different groups. Expression of autophagy-related genes had no significant changes in non-tumour 
livers compared with livers of CSAA diet-fed mice, but was significantly altered in the presence of tumors; e) changes in gene expression; expression of Atg9b was 
significantly reduced. 
 
To better understand the defect of autophagy in 
hepatocarcinogenesis of CDAA diet-fed mice, we 
performed PCR profiler array to analyze the global 
regulation of autophagy-related genes in hepatocytes 
from livers with or without tumors (Fig. 3d). Subsets 
of down-regulated or up-regulated autophagy-related 
genes were identified. Only minor changes in 
expression of autophagy-related genes were observed 
in hepatocytes from CSAA diet-fed mice and CDAA 
diet-fed mice without tumors. However, significant 
changes in the expression of autophagy-related genes 
were detected in hepatocytes from mice bearing 
hepatic tumors. These expression changes included 
up-regulation of lysosome-related genes (Hsp90aa1, 
Lamp1, Hspa8) in response to accumulated 
ubiquitinated proteins and down-regulation of genes 
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that encode proteins involved in autophagy 
regulation (Fig. 3e).  
Loss of Atg9b is sufficient to increase ER stress 
and cell death in hepatocytes 
Among the down-regulated genes, Atg9b was 
specifically involved in vacuole formation during 
autophagy initiation. Interestingly, expression of the 
other Atg9 homolog Atg9a was minimally changed. 
Compared with its expression in the livers of mice fed 
with CSAA diet, hepatic Atg9b was gradually 
repressed in the livers of CDAA diet-fed mice (Fig. 
4a), but its expression was not significantly reduced 
(Fig.4a). The protein level of Atg9b was particularly 
reduced in hepatocytes from livers with tumors 
compared with those without tumors (Fig. 4b). We 
further analyzed the expression of Atg9b in human 
clinical specimens by qRT-PCR, The results revealed 
that expression of Atg9b was significantly higher in 
the normal liver than in the liver with HCC (Fig.4c). 
We then knock-downed Atg9b expression in the 
hepatocyte cell line AML12 using RNA interference. 
Immunoblotting analysis showed that RNA 
interference against Atg9b could successfully reduce 
Atg9b expression without affecting Atg9a (Fig.4d). 
Reduced expression of Atg9b caused significantly 
increased cell death induced by ER stress stimulus 
including 1μM thapsigargin (TG), 0.5μM calcium 
ionophore A23187, and 5μM tunicamycin (TM) (Fig. 
4d). These results indicated that Atg9b may have a 
protective role in hepatocytes under ER stress 
stimulus. Although ER stress did not alter the 
expression of Atg9b in hepatocytes (Supplemental 
Figure 7), Atg9b silencing further induced an 
increasing expression of ER stress markers in 
hepatocytes exposed to the stimulus (Fig.4e). This 
may possibly be due to the accumulation of 
ubiquitinated proteins upon loss of Atg9b in 
hepatocytes as an ectopically expressed ubiquitinated 
protein CL1 was increased in Atg9b-deficient 
hepatocytes (Fig. 4f). These findings suggest that loss 
of Atg9b in hepatocytes during hepatic carcinogenesis 
is sufficient to cause decrease in autophagy that 
results in aggregation of ubiquitinated prone proteins 
and subsequent ER stress-associated cell death. 
Atg9b loss leads to defects in autophagic 
clearance of misfolded proteins in hepatocytes 
Autophagy is normally initiated by fusing the 
autophagosomes with lysosomes during ER stress to 
degrade damaged or misfolded proteins [23]. By 
treating AML12 cells with different ER stress stimuli 
including calcium ionophore A23187 and tunicamycin 
(TM), we observed a potent ER stress (Supplemental 
Figure 7) and autophagy initiation. Silencing Atg9b 
reduced the conversion of LC3 proteins leading to 
accumulation of p62 (Fig. 5a). To further elucidate the 
role of Atg9b in mediating induction of autophagy, 
we expressed LC3 proteins tagged with 
EGFP-mCherry in AML12 cells. Presentation of red 
but not green signals in A23187-treated AML12 cells 
revealed that cells underwent a complete process of 
autophagy; while expression of both green and red 
signal in cells with reduced Atg9b expression 
indicated blockade of autophagy (Fig.5b). EGFP 
signal was quenched in the acidic environment when 
LC3-formed autophagosomes were fused with 
lysosomes for degradation while the mCherry signal 
was pH insensitive. This result indicated that loss of 
Atg9b was sufficient to block the lysosomal 
degradation of the autophagic compartment. 
Suppression on Atg9b expression had minimal effect 
on the expression or cellular localization of LAMP-2, 
the docking protein expressing on lysosome which is 
necessary for the lysosomal degradation of the 
autophagic compartment (Supplemental Figure 8). To 
further understand which process of autophagy was 
blocked in Atg9b-deficient cells, we conducted 
endogenous co-immunoprecipitation assays. Pull 
down of Atg5, Atg12, LC3 or p62-containing protein 
complex was performed with corresponding 
antibodies, and protein-protein interactions were 
measured by immunoblotting. Interestingly, 
interactions of Atg5-Atg12, Atg5-LC3 and Atg12-LC3 
remained normal when we blocked Atg9b expression 
in AML12 cells. Loss of Atg9b was sufficient to cause 
reduced recruitment of p62 to Atg5-Atg12-LC3 
compartments (Fig.5c). This may indicate that p62 
accumulation in Atg9b-deficient hepatic cells was 
partially, if not entirely, due to the inability of p62 to 
attach to phagophore membrane. This was further 
confirmed by the observation that p62 and LC3 were 
not co-localized in Atg9b-deficient cells (Fig. 5d). To 
understand that p62 may function as a cargo between 
ubiquitinated protein aggregates and LC3 during 
autophagic degradation of misfolded proteins [24], 
we examined if decreased Atg9b expression could 
block the associations of the protein complex. It was 
evident that p62 could be recruited to ubiquitinated 
proteins during ER stress regardless of the expression 
status of Atg9b (Fig. 5e). However, co-localization of 
LC3 and ubiquitinated proteins could not be observed 
when Atg9b was repressed (Fig. 5f) resulting in 
further accumulation of ubiquitinated proteins in cells 
undergoing ER stress. To investigate if knockdown of 
Atg9b would lead to cancerous transformation-like 
changes in hepatocytes, we examined the 
proliferation and migration of Atg9b-deficient 
hepatocytes using colony formation in soft agar and 
migration assays. We observed that suppression of 
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Atg9b could increase formation of cell colonies in soft 
agar in the presence of sustained treatment with ER 
stress inducer A23187 (Fig. 5g). Increased migration 
away from the ER stress inducer A23187 was also 
detected in Atg9b-deficient cells (Fig. 5h). Thus, it 
appears plausible that repression of Atg9b can shift 
the non-cancerous cells to a more cancerous 
phenotype. These findings may further explain the 
essential role of Atg9b in autophagic clearance of ER 
stress-produced ubiquitinated proteins during 
hepatocarcinogenesis.  
 
 
Figure 4. Atg9b deficiency causes accumulation of ubiquitinated protein aggregates and increases cell death in hepatocytes a) expression of Atg9b 
but not Atg9a was significantly suppressed in the livers of mice fed with CDAA diet; b) expression of Atg9b was particularly suppressed in CDAA diet-fed mice with 
hepatic tumors (T) but not those without tumors (NT); c) expression of Atg9b was reduced in human HCC samples compared with non-tumour tissues; d) 
suppression of Atg9b resulted in increased cell death of hepatocytes in the presence of ER stress inducers 1μM TG, 5μM TM or 0.5μM A23187 for 6 hours; e) 
suppression of Atg9b resulted in increased ER stress in hepatocytes; f)suppression of Atg9b resulted in accumulation of ubiquitinated CL1 proteins. 
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Figure 5. Suppression of Atg9b leads to failure in autophagic degradation of ubiquitinated protein aggregates a) suppression of Atg9b caused deficiency in 
autophagy initiation. Inhibiting Atg9b expression in hepatocytes led to failure in LC3 conversion and accumulation of p62; b) Inhibition of Atg9b reduced fusion of lysosomes with 
autophagosomes; c) Inhibition of Atg9b reduced association of p62 with proteins forming autophagic vacuoles; d) Atg9b suppression reduced co-localisation of p62 with LC3B; 
e) inhibition of Atg9b did not reduce co-localization of p62 with ubiquitinated-prone proteins; f) suppression of Atg9b led to failure of co-localization of LC3B with ubiquitinated 
protein aggregates. g) suppression of Atg9b led to anchorage-independent growth of A23187-treated AML12 cells on soft agar; h) suppression of Atg9b increased migratory 
ability of AML12 cells away from the stress inducer A23187. 
 
microRNA-3091-3p from tumor-derived 
exosomes can suppress Atg9b expression in 
hepatocytes 
To better understand how Atg9b was aberrantly 
regulated in hepatocytes during hepatic 
carcinogenesis, we examined the expression of 
microRNAs that were predicted to target 3’UTRs of 
murine Atg9b. Interestingly, in CDAA diet-fed mice, 
hepatic mmu-miR-3091-3p was considerably elevated 
(Fig. 6a). In particular, this miRNA was significantly 
increased in hepatocytes from livers with tumors 
compared with those without tumors (Fig. 6b). 
Furthermore, expression of miR-3091-3p was higher 
in murine tumour cell lines (Supplemental Figure 9). 
Overexpression of mmu-miR-3091-3p in AML12 cells 
could suppress Atg9b while knockdown of the 
miRNA restored Atg9b at both mRNA and protein 
levels (Fig.6c&d). To prove that mmu-miR-3091-3p 
can target 3’UTR of murine Atg9b, we expressed 
luciferase-tagged 3’UTR of Atg9b in AML12 
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hepatocytes. Co-expression of the inhibitor against 
mmu-miR-3091-3p restored luciferase signal intensity 
while miRNA mimics further reduced 3’UTR 
transcription (Fig.6e). It was previously reported that 
hepatic cancer cells can secrete exosomes to shuttle 
molecules that facilitate the oncogenic transformation 
of normal hepatocytes [25]. We harvested exosomes 
from the conditioned medium of Hepa1-6 cells to 
determine their involvement in the regulation of 
Atg9b in hepatocytes (Fig.6f). Incubation of SYTO 
RNA-select Green-stained exosomes with AML12 
cells reveals that normal hepatocytes can absorb 
tumour-derived exosomes (Supplemental Figure 10). 
Expression of miR-3091-3p was up-regulated in 
hepatocytes internalising tumour-derived exosomes 
(Fig.6g). Initiation of autophagy by ER stress inducer 
was attenuated by transfection with miR-3091-3p 
mimics. Furthermore, miR-3091-3p can reduce the 
formation of autophagic punctas, leading to 
accumulation of p62 (Fig. 6h&i). Taken together, these 
observations indicated that miR-3091-3p in tumour 
cell-derived exosomes may be able to suppress Atg9b 
expression during the cancerous transformation of 
hepatocytes.  
 
 
Figure 6. Tumour cell-derived exosomes lead to Atg9b repression in hepatocytes a) expression of miR-3091-3p was induced in liver of mice with CDAA diet; b) 
expression of miR-3091-3p was significantly elevated in CDAA diet-fed mice with hepatic tumors (T) compared with those without tumors (NT); c) miR-3091-3p reduced mRNA 
expression of Atg9b in murine hepatocytes which were transfected with either mimics or inhibitor of miR-3091-3p; d) mimics of miR-3091-3p reduced Atg9b protein expression 
while inhibitor of miR-3091-3p restored Atg9b protein; e) miR-3091-3p bound 3’UTR of Atg9b mRNA; f) protocol of isolation and staining of tumor cells-derived exosomes; g) 
addition of exosomes induced expression of miR-3091-3p in hepatocytes; h) miR-3091-3p mimics could suppress LC3 conversion and accumulation of p62 in the presence of 
A23187; i) miR-3091-3p mimics could reduce LC3 punctuation leading to increased intracellular p62 level. 
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Discussion 
In this study, we observed that excessive ER 
stress was a distinctive feature of hepatocytes from 
livers with tumours, which showed an elevated 
expression of ER stress-related proteins such as 
GRP78. This observation could reflect the clinical 
characteristics of the early stage of HCCs, as 
expression of GRP78 mRNA had a positive correlation 
with staging of HCC as well as ER stress response in 
hepatocytes [26]. Accelerated ER stress accompanies 
autophagy deficiency during carcinogenesis, leading 
to increased death of hepatocytes. We identified that 
an Atg9 homolog Atg9b was down-regulated in 
hepatocytes during carcinogenesis of the liver. Atg9 
proteins were identified as the integral proteins that 
are required for the formation of autophagosomes 
and initiation of autophagy in mammalian cells [27]. 
Knockdown of Atg9b reduced LC3 lipidation as well 
as autophagic punctuations which appear to reflect 
the essential roles of Atg9 proteins in autophagy [28]. 
Interestingly, in our study, we did not observe any 
increase in the expression of Atg9b or its assembly 
into the PAS membrane during the ER stress. 
Although the expression of Atg9 proteins could be 
regulated via a transcriptional mechanism [29], the 
function of Atg9 proteins is dependent on a transient 
and dynamic interaction with autophagosomes [30]. 
This activity of Atg9 proteins requires a series of 
post-transcriptional modifications [31], but a 
reduction in Atg9 expression leads to failure of 
autophagosome formation and autolysosome 
compartmentalisation [32]. Atg9 protein is essential in 
autophagy induced by oxidative stress because of its 
ability to function as a source for autophagosome 
assembly [33]. We found that cells with reduced 
expression of Atg9b underwent exacerbated ER stress 
and increased UPR. Autophagy for the quality control 
of ER was independent of UPR. On the contrary, Atg9 
proteins were necessary for ER stress-related protein 
deposition via autophagy-lysosome pathway [34]. As 
a progressive ER stress was shown to largely 
contribute to hepatocarcinogenesis, our findings 
together with previous studies define the important 
role of Atg9b during liver carcinogenesis. 
Interestingly, consistent with our current data, a 
recent study showed that decreased expression of 
Atg9b but not its ortholog Atg9a could influence 
breast cancer and directly accelerated tumour 
progression [35]. This was the only published study 
showing difference of clinical significance of Atg9 
homologs. The study also showed that expression of 
Atg9a was related to the risk of cancer metastasis 
while decreased Atg9b was related to the ability to 
protect the normal epithelial tissues [35], indicating 
that the molecular functions of Atg9a and Atg9b may 
not be exactly complementary and biologically 
equivalent. 
We observed accumulation of p62 in hepatocytes 
in response to autophagy deficiency which was 
consistent with a previous study reporting the same in 
tumour cells [36]. The role of p62 in 
hepatocarcinogenesis has been extensively studied 
and was comprehensively reviewed in some recent 
publications [37, 38]. An Atg7/p62 DKO mice showed 
decreased liver tumoriogenesis supporting the notion 
that p62 accumulation can promote 
hepatocarcinogenesis [39]. Multiple pathways have 
been reported to be involved in this process. 
Accumulation of p62 can persistently activate Nrf2 
and its downstream target genes, which in turn 
promote sustained anchorage-independent growth of 
HCC cells during hepatoma development [40]. 
Accumulation of p62 can also impair DNA damage 
response by binding to nuclear RNF168 and inhibiting 
histone H2A ubiquitination. Consequently, the DNA 
repair proteins such as BRCA1, RAP80, and Rad51 
cannot be recruited to DNA double-strand breaks 
sites leading to genome instability and carcinogenesis 
[41].By activating NRF2, and mTORC1 and inducing 
c-Myc, p62 sustains the stressed tumour-initiating 
cells in HCC. p62 is necessary and sufficient for HCC 
induction in mice and is indicative of high recurrence 
of tumours after curative resection [42]. The elevated 
level of p62 in hepatocytes from livers with tumors 
compared to those without tumors may be due to a 
deficiency of autophagic degradation. It could also be 
due to a positive feedback loop of transcriptional 
activation of p62 in response to deposition of protein 
aggregates, asp62 has been shown to mediate their 
removal via autophagy to ensure genome stability [7, 
22].  
Our study indicated that p62 accumulation was 
probably due to the loss of assembly of protein 
aggregates in autophagic vacuoles in Atg9b-deficient 
cells. Since we did not observe dissociation of 
Atg5-Atg12-LC3 complex, accumulation of p62 could 
have been due to the loss of essential phagophores 
that mediate p62 docking on autophagic membranes. 
Whether lipidated LC3 has a direct association with 
p62 during autophagic protein degradation is so far 
controversial [43, 44]. Data from our study support 
the concept that Atg9b-driven phagophores may 
enable docking of both LC3 and p62 during 
autophagic protein degradation. Furthermore, 
accumulation of p62 may activate 
inflammation-related NF-κB signalling and induce 
production of ROS, which, in turn, leads to 
double-strained DNA break (DSB)-associated genome 
instability [37]. Transgenic mice overexpressing p62 
were prone to tumorigenesis when challenged by 
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carcinogens [45]. These oncogenic consequences of 
p62 accumulation in hepatocytes further suggest 
deficiency of autophagy by Atg9b loss may play a 
fundamental role in mediating hepatic carcinogenesis. 
Tumour-derived exosomes selectivity target 
peritumour hepatocytes, , although the mechanism of 
this selectivity remains obscure. A recent study 
showed that the protein Vps4A, which is critical for 
exosome biogenesis and uptake, was down-regulated 
in human HCC tissue reducing the exosome uptake 
by HCC cells [46]. Another study reported the 
possibility that tumour cells, which have a distinct 
miRNA profile, could selectively transfer specific 
miRNAs, that do not favor their survival and 
proliferation, to exosomes [47]. This selectivity may 
allow tumour cells to maintain partial ability to 
induce autophagy, which is still important for their 
survival and tolerance to multiple environmental 
stresses. Another possible scenario is that, 
tumour-derived exosomes bring epigenetic factors 
that can alter the miRNA profile of recipient cells, 
which, in turn, regulate the cellular biological 
processes. The influence of exosomes on miRNA 
profile on recipient cells could be global and 
non-specific with the overall consequence of 
tumorigenesis [48]. 
In conclusion, we elucidated the important role 
of Atg9b in hepatocarcinogenesis. Atg9b was 
down-regulated in human HCC specimens and was 
particularly suppressed in hepatocytes during 
carcinogenesis. Down-regulation of Atg9b resulted in 
deficient autophagy, accumulation of p62 and 
increased ER stress-related inflammation, genome 
instability, and cell death of hepatocytes. In vitro 
silencing of Atg9b was sufficient to suppress 
autophagy in response to ER stress. Hepatocytes 
without cytoprotective autophagy were more 
susceptible to exacerbated ER stress caused by 
accumulation of ubiquitinated proteins and were 
vulnerable to cell death. Loss of Atg9b blocked 
recruitment of p62-associated ubiquitinated proteins 
towards autophagosome-lysosome degradation. 
Atg9b-driven phagophores likely facilitated docking 
of both LC3 and p62 to initiate autophagy-associated 
degradation. miR-3091-3p from tumour-derived 
exosomes, which were internalized by hepatocytes, 
could repress Atg9b expression. Thus, observations of 
this study extend our knowledge about regulation of 
autophagy during hepatocarcinogenesis. 
Materials and Methods 
Choline deficient, amino acid-defined (CDAA) 
hepatocarcinogenesis model in mice 
Protocol of animal study was approved by the 
Committee on the Use of Live Animals in Teaching 
and Research (CULATR) of The University of Hong 
Kong. Mice were fed with CDAA diet for 32, 56, and 
72 weeks, or with CSAA diets as controls which were 
identical to CDAA diets in every respect except that 
choline was not omitted from the formulation [15]. 
Animals were monthly weighted. At the end of each 
study, mice were sacrificed and subjected to 
biomedical analysis. 
Plasmids, siRNAs, cells, and cell culture 
pBABE-puro Plasmids expressing 
mCherry-EGFP-LC3B were obtained from Addgene 
(USA, item #22418). All siRNAs, miRNA mimics, and 
miRNA inhibitors were obtained from Qiagen 
(Germany). Murine hepatocyte cell line AML12 and 
murine HCC cell line Hepa1-6 were obtained from 
ATCC (USA). AML12 cells were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) and 
Ham’s F12 Nutrient Mixture (F12) supplemented with 
10% Fetal Bovine Serum (FBS), 1% antibiotics, 0.005 
mg/ml insulin, 0.005 mg/ml transferrin, 5 ng/ml 
selenium, and 40 ng/ml dexamethasone. Hepa1-6 
cells were cultured in DMEM medium supplemented 
with 10% FBS and 1% antibiotics. All cells were 
cultured under humidified condition at 37℃ with 
5%CO2. 
PCR array and data analysis 
Murine Autophagy PCR array assay was 
conducted according to the manufacturer’s 
instructions (Qiagen, Germany). Results were 
normalized by expression of B2m, Actb and Gusb 
genes in average arithmetically. Scatter plot of 
differential expression between two groups was 
generated based on normalized expression of genes. 
On-Chip microarray 
RNA samples were labelled with miRCURY 
LNA™ microRNA Hi-Power Labelling Kit (Exiqon, 
Denmark), Hy3™/Hy5™ and hybridized on the 
miRCURY LNA™ microRNA Array (7th Gen, Exiqon, 
Denmark) following a dual-color experimental 
design. Data analysis was conducted following 
normalization of the quantified signals (background 
corrected) using the global Lowess regression 
algorithm of Agilent. 
Quantitative Real-time PCR 
Total RNA was isolated using Trizol and cDNA 
was synthesized with robust kit (Takara, Japan) or 
miRNA-specific kit (Exiqon, Denmark). Gene 
expression was determined by quantitative real-time 
PCR (LightCycler 480, Roche, USA) with SYBR Green 
Probe (Takara, Japan) or LNA Probe (Exiqon, 
Demark) with gene-specific primers. 
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Co-immunoprecipitation 
Cells were lysed with NF-40 cell lysis buffer (Life 
Technologies, USA) supplemented with cocktail 
proteinase inhibitor (Roche, USA). Cell lysate was 
then incubated with Protein G magnetic beads 
(Millipore, USA) pre-conjugated with specific 
antibody to pull down the protein complex.  
Immunoblotting 
Total proteins were separated by electrophoresis 
on an SDS-PAGE and then transferred to PVDF 
membrane (Bio-rad, USA). The membrane was then 
blocked with 5%BSA and incubated with specific 
primary antibodies overnight at 4℃, followed by 
incubation with corresponding secondary antibodies. 
Target blots were read under chemiluminescence 
(Biorad, USA) with ECL select as substrate (GE 
healthcare, UK). 
Exosome isolation and labelling 
Tumour cell-derived exosomes were collected 
from culture supernatants of Hepa1-6 cells. Briefly, 
cells were cultured in DMEM supplemented with 
exosomes-free FBS. Culture medium was collected 
and filtered, and exosomes were enriched with total 
exosome isolation reagent following the 
manufacturer’s instructions (Life Technologies, USA). 
For exosome labelling, SYTO RNA select (Life 
Technologies, USA) was used. Labelled exosomes 
were added to the culture medium of AML12 cells 
and incubated 1.5 hr to observe exosome uptake by 
hepatocytes. 
Soft Agar Assay 
1,000 AML12 cells was seeded in 0.7% top 
agarose in DMEM/F12 medium supplemented with 
0.5μM A23187 on top of 0.5% Agar base. Medium was 
replenished every 3 days for 21 days. At the end of 
study, cells were stained with 0.005% crystal violet in 
methanol for 2 hours and washed cell colonies were 
counted. 
Migration assay 
50,000 AML12 cells in serum free-DMEM/F12 
medium were seeded onto the transwell chamber 
(8μm, Corning, USA). Receiving chamber was 
supplemented with DEMEM/F12 medium with 10% 
FBS. ER stress inducer A23187 was added to the 
transwell chamber with final concentration of 0.5μM. 
6 hours after cell seeding, cells at the bottom of 
transwell chamber were fixed in 4% PFA and stained 
with 2% crystal violet. Number of cells were counted 
under light microscope.  
Statistical Analysis 
Results were presented in mean±standard 
deviation (SD). Statistical analysis was conducted 
with ONE-WAY ANOVA and p value less than 0.05 
was considered significant statistically. 
Supplementary Material  
Supplementary figures and tables.  
http://www.thno.org/v07p2325s1.pdf   
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